Interestingly, overexpressed RPs have also been reported in cancers, such as eL15/RPL15 in breast cancer, promoting cell cycle and metastasis [67], and in melanoma, reducing stress signalling and anti-tumorigenic response [68]. This evidence concerns the gene RPL15 and cancer.